Evidence map›Paper›PMID 40893475›Full record

ReviewAdvances in ophthalmology practice and research

Multimodal data-driven approaches in retinal vein occlusion: A narrative review integrating machine learning and bioinformatics.

Chunlan Liang, Lian Liu, Jingxiang Zhong

Abstract readReview
In one paragraph

Review in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chunlan LiangDepartment of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Lian LiuDepartment of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Jingxiang ZhongDepartment of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Retinal vein occlusion (RVO) is a leading cause of visual impairment on a global scale. Its pathological mechanisms involve a complex interplay of vascular obstruction, ischemia, and secondary inflammatory responses. Recent interdisciplinary advances, underpinned by the integration of multimodal data, have established a new paradigm for unraveling the pathophysiological mechanisms of RVO, enabling early diagnosis and personalized treatment strategies. Main text: This review critically synthesizes recent progress at the intersection of machine learning, bioinformatics, and clinical medicine, focusing on developing predictive models and deep analysis, exploring molecular mechanisms, and identifying markers associated with RVO. By bridging technological innovation with clinical needs, this review underscores the potential of data-driven strategies to advance RVO research and optimize patient care. Conclusions: Machine learning-bioinformatics integration has revolutionised RVO research through predictive modelling and mechanistic insights, particularly via deep learning-enhanced retinal imaging and multi-omics networks. Despite progress, clinical translation requires resolving data standardisation inconsistencies and model generalizability limitations. Establishing multicentre validation frameworks and interpretable AI tools, coupled with patient-focused data platforms through cross-disciplinary collaboration, could enable precision interventions to optimally preserve vision.

Indexed as

BioinformaticsClinical prediction modelsDeep learningMachine learningMarkersMultimodal dataRetinal vein occlusion

Identifiers

PMID40893475
PMCPMC12398838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.